AVMA Veterinary Practice Advertising Ethics
Veterinary advertising must not be false or misleading; only veterinarians certified by an AVMA-recognized specialty organization should be called specialists, and outcomes must not be guaranteed.
Veterinary advertising must not be false or misleading; only veterinarians certified by an AVMA-recognized specialty organization should be called specialists, and outcomes must not be guaranteed.
Objective ad claims must be truthful and substantiated before they run, with material terms and typical results disclosed; puffery is not covered.
Prohibits false or misleading representations in Canadian advertising, judged by general impression, and requires performance claims to rest on adequate and proper testing.
Performance and superiority claims for Canadian financial products, such as 'lowest rate' or 'fastest approval', must be accurate and supported by adequate and proper testing before publication.
Program marketing at Title IV institutions must not misrepresent graduate earnings or outcomes, and programs warned under the Gainful Employment rule must give the required student warning; rule status is in flux after the 2025 budget law.
PSLF marketing must accurately describe the program: Direct Loans, full-time qualifying employment, 120 qualifying payments under a qualifying plan, a free application, and no expired waivers or ended plans presented as available.
EU cosmetic claims in labelling and advertising must be truthful, supported and fair under Reg. 655/2013, may not claim to treat disease, and labels must carry the Art. 19 information.
REACH governs chemicals in EU products; in marketing, chemical free-from and REACH-status claims must be accurate and not misleading, and REACH compliance may not be presented as a distinctive benefit.
Financial firms in DORA scope must not market absolute uptime or security claims or claim a DORA certification that does not exist.
UK insurance price and savings claims must state their basis and not mislead; 'up to' savings must be achievable by a significant share of customers.
Device promotion must not make false, absolute or unsubstantiated performance, safety or superiority claims; quantified and comparative claims need a cited basis.
Testing, purity and certification-seal claims for supplements, CBD and OTC products must be truthful and match what was actually tested or certified.
Broker-dealer app messages, AI-tool claims and crypto offerings must be fair and balanced, must not overstate AI, and must not equate crypto with cash or SIPC/FINRA protection.
Bars deceptive safety, testing and agency-approval claims in marketing of children's products, such as 'CPSC approved' or absolute safety claims.
The FTC Act bars deceptive advertising: objective claims need a reasonable basis before they run, and qualifications and material terms must be clear and conspicuous so the net impression is not misleading.
Under FTC Act Section 5, advertisers must substantiate claims about AI capabilities and must not use AI-generated or synthetic people, voices or demonstrations in a way that misleads consumers about endorsements or results.
Clinical-proof claims, testimonials and endorsements for CBD products must be backed by fitting evidence, reflect typical results and disclose material connections.
Cosmetic performance and efficacy claims must be substantiated, and claims to treat disease or change body function turn a cosmetic into a drug.
Cosmetic safety, testing, natural and organic claims must be substantiated and match the product's ingredients; USDA organic labeling requires certification.
Unqualified 'Made in USA' and similar claims, including hashtags and seals, require final assembly, all significant processing and all or virtually all components in the U.S.; otherwise claims must be clearly qualified.
Efficacy, speed and comparative claims for OTC drugs require competent and reliable scientific evidence matching the strength of the claim.
Advertisers must have a reasonable basis for objective claims before making them, with at least the level of proof the claim itself states.
Sports nutrition claims need competent and reliable scientific evidence, generally human trials on the product, and ads must not overstate the studies they cite.
Kansas insurance ads must not make false or misleading savings, price, comparison or testimonial claims; savings figures need a stated basis.
Montana bars untrue, deceptive or misleading PBM marketing; savings, pricing-model, network and cost-share claims must be accurate and qualified.
Municipal advisor advertising must be fair and balanced and must not contain false, exaggerated, unwarranted or misleading statements, including unsupported rankings or promised outcomes.
Advertisers need a reasonable basis for objective claims before they run, with evidence matching the claim's scope; the rule flags unqualified objective claims for substantiation review.
Vehicle safety claims must be truthful and substantiated, NHTSA ratings must be described accurately, and ads must not imply NHTSA approval or overstate driver-assistance features.
Under NAD/NARB self-regulatory precedent, objective, comparative and 'free' claims need adequate support and clear, conspicuous qualifying disclosures near the claim.
Credit union security claims must not be absolute or misleading about fraud risk or member liability.
New York personal care and cosmetic marketing must not make unqualified 'clean', 'non-toxic' or 'chemical-free' claims or free-of claims the product cannot support.
Crypto mining marketing reaching New Yorkers must not guarantee income, must qualify ROI projections and must support environmental claims.
Stablecoin and tokenized-asset marketing must not misstate reserves, backing, redemption or audit status.
A bank that cites its CRA rating in marketing must use the official rating category accurately and must not present it as a ranking or government endorsement.
Mortgage marketing that relies on HMDA data must accurately reflect the data cited and must not imply regulatory endorsement or that the bank approves everyone.
Puerto Rico real estate ads must not misstate property facts, guarantee returns or blur whom the licensee represents.
Investment adviser ads showing hypothetical, backtested or projected performance must label it, explain its criteria, assumptions, risks and limitations, and keep it out of mass-audience channels.
Absolute or risk-free claims about outcomes, safety or capability must be true and substantiated; unqualified certainty claims are deceptive.
Specific dollar savings, price, bonus or payout claims in insurance ads must state their basis and conditions so they are not misleading.
Expert or professional preference claims must be truthful, substantiated and given by people with the expertise claimed.
Requires 'studies show', survey and test claims to be supported by competent evidence, and flags such claims that give no identifiable basis or overstate what the cited source shows.
Med spa ads for medical aesthetic procedures must not claim no risk, guaranteed or permanent results, or imply prescription drugs need no evaluation, and must be accurate about who performs procedures.
Texas Lottery ads must be truthful about odds and prizes, avoid skill or guaranteed-win claims, and not appeal to minors.
Bars implied government approval and unqualified comparative efficiency claims in ads for DOE-covered appliances; representations must rest on DOE test procedures.
FDA recommends that consumer-directed prescription drug promotion stating efficacy or risk numbers give absolute frequencies for the drug and control groups, use consistent formats, and avoid relative-only figures that overstate benefit.
Data in promotion that are not in the labeling, including real-world evidence, must be consistent with the approved conditions of use and be presented with the study design, limitations and context needed to avoid misleading the reader.
Promotion may not represent or suggest that a prescription drug or biologic is more effective, more durable or useful in a broader range of conditions than substantial evidence shows.
Firm communications to HCPs about unapproved uses must be scientifically sound, kept separate from promotion, free of persuasive elements and accompanied by disclosures: the use is unapproved, the approved uses and labeling, study design and limitations, conflicting data and financial ties.
UK ads using AI-generated content must not mislead about results or who is speaking; disclosure is needed only where omission would mislead and does not cure a misleading image.
Vermont fantasy sports ads must be truthful about prizes, winnings and bonuses and must not target minors.
Virginia's false advertising statute bars untrue, deceptive or misleading statements of fact in advertising to Virginia consumers.